Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabetta Gazzerro

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|July 4, 2012
Hypomyelination and congenital cataract: identification of novel mutations in two unrelated familiesMonica Traverso, Ozge Ozalp Yuregir, Aviva Mimouni-Bloch, et al.
The American Journal of Pathology|March 23, 2010
Therapeutic potential of proteasome inhibition in Duchenne and Becker muscular dystrophiesElisabetta Gazzerro, Stefania Assereto, Andrea Bonetto, et al.
Clinical Endocrinology|December 18, 2003
A reappraisal of the Rb1 gene abnormalities in the diagnosis of parathyroid cancerFilomena Cetani, Elena Pardi, Paolo Viacava, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|June 14, 2016
The ubiquitin ligase tripartite-motif-protein 32 is induced in Duchenne muscular dystrophyStefania Assereto, Rosanna Piccirillo, Serena Baratto, et al.
The American Journal of Pathology|October 15, 2015
Enhancement of Muscle T Regulatory Cells and Improvement of Muscular Dystrophic Process in mdx Mice by Blockade of Extracellular ATP/P2X AxisElisabetta Gazzerro, Simona Baldassari, Stefania Assereto, et al.
Cell Cycle (Georgetown, Tex.)|July 22, 2008
Aquaporin-4 expression is severely reduced in human sarcoglycanopathies and dysferlinopathiesStefania Assereto, Mauro Mastrototaro, Silvia Stringara, et al.
The Journal of Clinical Endocrinology and Metabolism|November 9, 2004
Genetic analyses of the HRPT2 gene in primary hyperparathyroidism: germline and somatic mutations in familial and sporadic parathyroid tumorsFilomena Cetani, Elena Pardi, Simona Borsari, et al.
Pharmaceuticals (Basel, Switzerland)|January 21, 2022
P2X7 Receptor Antagonist Reduces Fibrosis and Inflammation in a Mouse Model of Alpha-Sarcoglycan Muscular DystrophyLizzia Raffaghello, Elisa Principi, Serena Baratto, et al.
British Journal of Pharmacology|August 4, 2018
Effects of non-euphoric plant cannabinoids on muscle quality and performance of dystrophic mdx miceFabio Arturo Iannotti, Ester Pagano, Aniello Schiano Moriello, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|March 20, 2010
The spectrum of GNE mutations: allelic heterogeneity for a common phenotypeMarina Grandis, Rossella Gulli, Denise Cassandrini, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|July 4, 2012
Hypomyelination and congenital cataract: identification of novel mutations in two unrelated familiesMonica Traverso, Ozge Ozalp Yuregir, Aviva Mimouni-Bloch, et al.
The American Journal of Pathology|March 23, 2010
Therapeutic potential of proteasome inhibition in Duchenne and Becker muscular dystrophiesElisabetta Gazzerro, Stefania Assereto, Andrea Bonetto, et al.
Clinical Endocrinology|December 18, 2003
A reappraisal of the Rb1 gene abnormalities in the diagnosis of parathyroid cancerFilomena Cetani, Elena Pardi, Paolo Viacava, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|June 14, 2016
The ubiquitin ligase tripartite-motif-protein 32 is induced in Duchenne muscular dystrophyStefania Assereto, Rosanna Piccirillo, Serena Baratto, et al.
The American Journal of Pathology|October 15, 2015
Enhancement of Muscle T Regulatory Cells and Improvement of Muscular Dystrophic Process in mdx Mice by Blockade of Extracellular ATP/P2X AxisElisabetta Gazzerro, Simona Baldassari, Stefania Assereto, et al.
Cell Cycle (Georgetown, Tex.)|July 22, 2008
Aquaporin-4 expression is severely reduced in human sarcoglycanopathies and dysferlinopathiesStefania Assereto, Mauro Mastrototaro, Silvia Stringara, et al.
The Journal of Clinical Endocrinology and Metabolism|November 9, 2004
Genetic analyses of the HRPT2 gene in primary hyperparathyroidism: germline and somatic mutations in familial and sporadic parathyroid tumorsFilomena Cetani, Elena Pardi, Simona Borsari, et al.
Pharmaceuticals (Basel, Switzerland)|January 21, 2022
P2X7 Receptor Antagonist Reduces Fibrosis and Inflammation in a Mouse Model of Alpha-Sarcoglycan Muscular DystrophyLizzia Raffaghello, Elisa Principi, Serena Baratto, et al.
British Journal of Pharmacology|August 4, 2018
Effects of non-euphoric plant cannabinoids on muscle quality and performance of dystrophic mdx miceFabio Arturo Iannotti, Ester Pagano, Aniello Schiano Moriello, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|March 20, 2010
The spectrum of GNE mutations: allelic heterogeneity for a common phenotypeMarina Grandis, Rossella Gulli, Denise Cassandrini, et al.
Pageof 5